guanfacine has been researched along with Left Ventricular Hypertrophy in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The left ventricular end systolic stress-end systolic dimension (ESS-ESD) relation was used to assess the effect of regression in left ventricular hypertrophy on myocardial contractility in 14 hypertensive patients (mean age 47 years) treated with guanfacine (a sympatholytic central alpha-adrenergic agonist) for 10 weeks." | 3.67 | Contractile performance following regression of left ventricular hypertrophy in hypertensive patients. ( el-Said, G; Emile, H; Ibrahim, MM; Madkour, MA, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ibrahim, MM | 1 |
| Emile, H | 1 |
| Madkour, MA | 1 |
| el-Said, G | 1 |
1 other study available for guanfacine and Left Ventricular Hypertrophy
| Article | Year |
|---|---|
Contractile performance following regression of left ventricular hypertrophy in hypertensive patients.
Topics: Adult; Guanfacine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardia | 1985 |